MeSH tree: D12.776.124.486.485.114.224.060.937
The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease. The new guideline uses cutting-edge network ...
Nov 20, 2025
0
26
Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern suggesting" a lower five-year risk of any first cancer (excluding non-melanoma skin cancer) with ustekinumab ...
In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) ...
Jul 17, 2025
0
29
Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and has a favorable safety profile with fewer serious adverse events compared to a placebo for individuals ...
A drug that is currently used for the treatment of psoriasis has been found to be effective in treating the early stages of type-1 diabetes in children and adolescents, finds a new clinical trial led by Cardiff University.
Jul 30, 2024
0
80
For patients with moderate-to-severe Crohn's disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the ...
Jul 18, 2024
0
43
A newly developed PET radiotracer can be used to create an inflammation map of the entire gastrointestinal tract, providing detailed information to accurately detect and stage inflammatory bowel disease (IBD). Targeting the ...
Nov 14, 2023
0
52
The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.
Nov 3, 2023
0
56
The mass and composition of our bodies can significantly affect the way medications are metabolized and absorbed. Investigators at Cedars-Sinai have found that inflammatory bowel disease (IBD) patients with higher levels ...
Jul 25, 2023
0
45
For many years, the Simple Endoscopic Score for Crohn's Disease, or SES-CD—a scoring method used in colonoscopies to measure healing and health of the gut—was the "gold standard" for evaluating Crohn's disease patients, specifically, ...
Sep 20, 2022
0
42
